Marshall Wace’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.59M | Sell |
511,412
-327,040
| -39% | -$1.66M | ﹤0.01% | 1345 |
|
|
2025
Q1 | $2.53M | Buy |
+838,452
| New | +$2.53M | ﹤0.01% | 1280 |
|
|
2024
Q4 | – | Sell |
-14,031
| Closed | -$24.7K | – | 2879 |
|
|
2024
Q3 | $24.7K | Buy |
+14,031
| New | +$24.7K | ﹤0.01% | 2237 |
|
|
2024
Q2 | – | Sell |
-158,619
| Closed | -$309K | – | 2779 |
|
|
2024
Q1 | $309K | Buy |
+158,619
| New | +$309K | ﹤0.01% | 1841 |
|
|
2023
Q2 | – | Sell |
-10,947
| Closed | -$23K | – | 2597 |
|
|
2023
Q1 | $23K | Sell |
10,947
-129,349
| -92% | -$272K | ﹤0.01% | 2062 |
|
|
2022
Q4 | $307K | Sell |
140,296
-35,614
| -20% | -$78K | ﹤0.01% | 1977 |
|
|
2022
Q3 | $527K | Buy |
175,910
+16,503
| +10% | +$49.4K | ﹤0.01% | 2020 |
|
|
2022
Q2 | $450K | Sell |
159,407
-43,600
| -21% | -$123K | ﹤0.01% | 2175 |
|
|
2022
Q1 | $1.09M | Sell |
203,007
-47,389
| -19% | -$254K | ﹤0.01% | 1831 |
|
|
2021
Q4 | $1.87M | Buy |
250,396
+207,390
| +482% | +$1.55M | ﹤0.01% | 1638 |
|
|
2021
Q3 | $390K | Buy |
+43,006
| New | +$390K | ﹤0.01% | 1961 |
|